XAF1 as a modifier of p53 function and cancer susceptibilityEmília M. Pinto, Michael R. Clay, Maria Nirvana Formiga et al.|Science Advances|2020Cited by 58
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)Nizar M. Tannir, Oleg Karyakin, Maria Nirvana Formiga et al.|Journal of Clinical Oncology|2024Cited by 26